U.S.-China Program for Biomedical Collaborative Research (R01)
Funding Opportunity Number: RFA-AI-16-006 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.24293.85393.85593.856Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3)...
Source: Grants.gov - December 11, 2015 Category: Research Tags: Health Source Type: funding
U.S.-China Program for Biomedical Collaborative Research (R01)
Funding Opportunity RFA-AI-16-006 from the NIH Guide for Grants and Contracts. The purpose of the U.S.-China Program for Biomedical Collaborative Research is to stimulate collaborative basic, translational, and clinical research between United States (U.S.)-based researchers and Chinese researchers in the areas of allergy, immunology, and infectious diseases including HIV/AIDS and its co-morbidities and co-infections, mental health, and selected neurological disorders. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 11, 2015 Category: Research Source Type: funding
Notice of an Update to the Key Dates in RFA-AI-15-041"Human Immunology Project Consortium (U19)"
Notice NOT-AI-16-011 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 27, 2015 Category: Research Source Type: funding
Notice of an Update to the Key Dates in RFA-AI-15-055 "B Cell Immunology Program for HIV-1 Vaccine Development (BCIP) (R01)"
Notice NOT-AI-16-010 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 24, 2015 Category: Research Source Type: funding
Human Immunology Project Consortium (U19)
Funding Opportunity Number: RFA-AI-15-041 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.85593.856Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c...
Source: Grants.gov - November 21, 2015 Category: Research Tags: Health Source Type: funding
Human Immunology Project Consortium (U19)
Funding Opportunity RFA-AI-15-041 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) on the Human Immunology Project Consortium (HIPC) solicits applications from single institutions, or consortia of institutions, to participate in a network of human immunology profiling research groups in the area of infectious diseases, including HIV. The purpose of this FOA is to characterize human immune responses/mechanisms elicited by vaccinations, adjuvants or natural infection by capitalizing on recent advances in immune profiling technologies. Studies supported under this FOA will measure...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 19, 2015 Category: Research Source Type: funding
Enhanced Surveillance for New Vaccine Preventable Diseases
Funding Opportunity Number: CDC-RFA-IP-16-004 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.185Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-CDCClosing Date: Jan 15, 2016Award Ceiling: $1,000,000Expected Number of Awards: 7Creation Date: Nov 13, 2015Funding Opportunity Description: The purpose of this announcement is to solicit applications for a research cooperative agreement that will fund a network of pediatric me...
Source: Grants.gov - November 15, 2015 Category: Research Tags: Health Source Type: funding
Studies of HIV in Digestive Diseases Limited to Gastrointestinal Mucosal Immunology and Liver Diseases (R01)
Funding Opportunity Number: RFA-DK-16-016 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: Food and NutritionHealthCFDA Number: 93.847Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3)...
Source: Grants.gov - November 4, 2015 Category: Research Tags: Food and Nutrition Health Source Type: funding
Studies of HIV in Digestive Diseases Limited to Gastrointestinal Mucosal Immunology and Liver Diseases (R01)
Funding Opportunity RFA-DK-16-016 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to support innovative, basic and translational, nonexempt human subjects research in two areas, gastrointestinal (GI) mucosal immunology and liver disease. The emphasis for GI mucosal immunology is on elucidation of mechanisms whereby innate and adaptive immunity in the GI tract interacts with HIV infection in the presence or absence of antiretroviral therapy (ART) and contributes to GI pathology.The emphasis for liver disease is on pathophysiologic mechanisms of injury to the live...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 3, 2015 Category: Research Source Type: funding
Notice of Termination of PA-14-216 "B Cell Help Immunology Program for AIDS Vaccine Strategies (R01)"
Notice NOT-AI-16-004 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 23, 2015 Category: Research Source Type: funding
B Cell Immunology Program for HIV-1 Vaccine Development (BCIP) (R01)
The objective of this Funding Opportunity Announcement (FOA) is to solicit hypothesis-driven, multidisciplinary research to elucidate the complexities and developmental plasticity of B cells associated with the induction of potent, durable, adaptive immune responses against HIV-1. (Source: Grants.gov)
Source: Grants.gov - October 21, 2015 Category: Research Tags: Health Source Type: funding
B Cell Immunology Program for HIV-1 Vaccine Development (BCIP) (R01)
The objective of this Funding Opportunity Announcement (FOA) is to solicit hypothesis-driven, multidisciplinary research to elucidate the complexities and developmental plasticity of B cells associated with the induction of potent, durable, adaptive immune responses against HIV-1. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 21, 2015 Category: Research Source Type: funding
BLM-Washington DC, Applicability and Efficacy of PZP on Wild Burros in Northwestern Arizona
Funding Opportunity Number: L16AS00001 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: Natural ResourcesCFDA Number: 15.229Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOI-BLMClosing Date: Dec 14, 2015Award Ceiling: $25,000Expected Number of Awards: 1Creation Date: Oct 14, 2015Funding Opportunity Description: Background: Wild Burro populations on BLM lands exceed allowable management lev...
Source: Grants.gov - October 15, 2015 Category: Research Tags: Natural Resources Source Type: funding
Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21)
Funding Opportunity Number: PAR-15-360 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.85593.856Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with th...
Source: Grants.gov - September 30, 2015 Category: Research Tags: Health Source Type: funding
Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21)
Funding Opportunity PAR-15-360 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support hypothesis-generating research on innate and adaptive immune responses induced by mycobacterial infection, Bacillus Calmette-Gurin vaccine (BCG), or other Mycobacterium tuberculosis (Mtb) vaccinations.Studies that include evaluation of immune responses by anatomical location in HIV-infected or uninfected individuals are of particular interest.A secondary objective of this FOA is development of new assays and technologies enabling comparison of mycobacterial-specific muco...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 30, 2015 Category: Research Source Type: funding
